Home
>
National Drug Code (NDC)
>
Plasma-Lyte 148
Plasma-Lyte 148 - 0338-0179-03 - (SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE)
Drug Information of Plasma-Lyte 148
| Product NDC: | 0338-0179 |
| Proprietary Name: | Plasma-Lyte 148 |
| Non Proprietary Name: | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| Active Ingredient(s): | 30; 37; 368; 526; 502 mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL & nbsp; SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Plasma-Lyte 148
| Product NDC: | 0338-0179 |
| Labeler Name: | Baxter Healthcare Corporation |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017378 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19790202 |
Package Information of Plasma-Lyte 148
| Package NDC: | 0338-0179-03 |
| Package Description: | 500 mL in 1 BAG (0338-0179-03) |
NDC Information of Plasma-Lyte 148
| NDC Code | 0338-0179-03 |
| Proprietary Name | Plasma-Lyte 148 |
| Package Description | 500 mL in 1 BAG (0338-0179-03) |
| Product NDC | 0338-0179 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | SODIUM CHLORIDE, SODIUM GLUCONATE, SODIUM ACETATE, POTASSIUM CHLORIDE, AND MAGNESIUM CHLORIDE |
| Dosage Form Name | INJECTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 19790202 |
| Marketing Category Name | NDA |
| Labeler Name | Baxter Healthcare Corporation |
| Substance Name | MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM ACETATE; SODIUM CHLORIDE; SODIUM GLUCONATE |
| Strength Number | 30; 37; 368; 526; 502 |
| Strength Unit | mg/100mL; mg/100mL; mg/100mL; mg/100mL; mg/100mL |
| Pharmaceutical Classes | Potassium Compounds [Chemical/Ingredient],Potassium Salt [EPC],Calculi Dissolution Agent [EPC],Magnesium Ion Exchange Activity [MoA] |
